Dr. David Vigerust of Spectrum Solutions to Deliver Keynote Address at ISBER 2022

PRESS RELEASE
Leslie Titus Bryant
May 10, 2022

SALT LAKE CITY, UTAH—May 10, 2022—Spectrum Solutions, LLC today announced its Chief Scientific Officer, David Vigerust, MS, Ph.D. will be delivering this year’s keynote address in Atlanta, Georgia, at the International Society for Biological and Environmental Repositories (ISBER) annual meeting and conference.

The international biobanking 4-day conference kicks off May 17th, closing business on May 20th, marking this the first time the ISBER has conducted its annual meeting in person since the beginning of the pandemic. Recorded meeting and conference events will be made available for delegates unable to attend in person.

ISBER has invited several prominent speakers from around the world to showcase the influence biobanking extends in shaping modern medicine and science, as well as its deep-rooted role in accelerating the scientific journey. Covered topics will include new applications in novel companion diagnostics, the convergence of biology with technology and the benefits and power of cross-sector partnerships contributing to a vibrant and rapidly growing industry.

Dr. Vigerust’s keynote address will reflect the evolving vision for the future of biobanking as seen through the lens of a scientist and dedicated investigator. He will highlight the trail-blazing risk-takers who have come before and those who continue to not only inspire but embrace, with dogged determination, the outside-the-box problem-solving mission to answer questions, seek solutions, accelerate innovation and impact outcomes. Additionally, he will discuss his extraordinary journey and unique contributions in receptor biology, viral-bacterial synergy and innate immunity underlining the importance of new diversity in biospecimens for opening doors to new and profound patient-empowering scientific discoveries.

ISBER is a global organization creating mind-share opportunities for ideas and biobanking innovation, fostering collaboration and harmonizing approaches. ISBER aims to evolve and resolve challenges in biological and environmental repositories as well as offer education and an international showcase for research findings, innovative technologies, products and services.

ISBER 2022

Dr. David Vigerust of Spectrum Solutions to Deliver Keynote Address at ISBER 2022

PRESS RELEASE
Leslie Titus Bryant
May 10, 2022

SALT LAKE CITY, UTAH—May 10, 2022—Spectrum Solutions, LLC today announced its Chief Scientific Officer, David Vigerust, MS, Ph.D. will be delivering this year’s keynote address in Atlanta, Georgia, at the International Society for Biological and Environmental Repositories (ISBER) annual meeting and conference.

The international biobanking 4-day conference kicks off May 17th, closing business on May 20th, marking this the first time the ISBER has conducted its annual meeting in person since the beginning of the pandemic. Recorded meeting and conference events will be made available for delegates unable to attend in person.

ISBER has invited several prominent speakers from around the world to showcase the influence biobanking extends in shaping modern medicine and science, as well as its deep-rooted role in accelerating the scientific journey. Covered topics will include new applications in novel companion diagnostics, the convergence of biology with technology and the benefits and power of cross-sector partnerships contributing to a vibrant and rapidly growing industry.

Dr. Vigerust’s keynote address will reflect the evolving vision for the future of biobanking as seen through the lens of a scientist and dedicated investigator. He will highlight the trail-blazing risk-takers who have come before and those who continue to not only inspire but embrace, with dogged determination, the outside-the-box problem-solving mission to answer questions, seek solutions, accelerate innovation and impact outcomes. Additionally, he will discuss his extraordinary journey and unique contributions in receptor biology, viral-bacterial synergy and innate immunity underlining the importance of new diversity in biospecimens for opening doors to new and profound patient-empowering scientific discoveries.

ISBER is a global organization creating mind-share opportunities for ideas and biobanking innovation, fostering collaboration and harmonizing approaches. ISBER aims to evolve and resolve challenges in biological and environmental repositories as well as offer education and an international showcase for research findings, innovative technologies, products and services.

ISBER 2022

Noninvasive
Saliva Diagnostics

This changes everything

Health is a dynamic state of well-being. Healthcare providers and researchers have long believed that changes in our saliva record our ongoing state-of-health story. Interestingly, saliva acts as a wide resource of genomic information useful for identifying and monitoring in real-time a disease as well as its state of progression. Saliva analysis looks at the cellular level, the biologically active compounds, making it a true representative of what is clinically relevant.

Spectrum’s technically-superior saliva collection systems have not only been engineered to lead the saliva collection industry in molecular diagnostics and clinical research applications but deliver the safest, most robust biomaterial for the earliest detection and diagnosis of disease and infection.

  • Saliva provides the earliest path to critical detection and diagnosis
  • Saliva contains the entire library of proteins, hormones, antibodies, and other molecular compounds measured in routine blood tests
  • First EUA authorized saliva collection device for COVID-19 testing & authorized device for direct-to-patient at-home sample self-collection
  • Used in supervised & unsupervised sample collection LDT workflows of symptomatic & asymptomatic users
  • Pain-free, non-invasive, & safe – ideal for those needing frequent & repeat testing
  • In-device live virus inactivation at ambient temps (COVID-19 EUA validated data)
  • Eliminates hooded containment of samples arriving at the testing lab
  • No temperature-controlled storage or transport of collected saliva samples
  • Single device for DNA & viral RNA applications
  • Safest collection approach & most robust biomaterial for detecting COVID-19
  • Delivers 99.998% highest levels of testing accuracy & sensitivity
  • Formulation identifies infections at its earliest stage from as few as 200 copies/ml (lateral flow rapid tests need 10,000-20,000 copies/ml)
  • A single preserved saliva sample provides opportunity for multiple tests
  • Over two weeks of post-collection stability with no degradation in sample efficacy
  • System maintains critical bio-sample consistency
  • Mass-testing scalability & easy device integration using validated and supported processes
  • Mitigates any risk of infection throughout the testing process
  • Pinpoint life-cycle stage of active viral infection
  • Eliminates UN3373 shipping designation with clearance from USPS, FedEx, & UPS
  • Delivers the highest levels of testing accuracy using qualified extraction chemistries
Questions, Let’s Connect!

Noninvasive
Saliva Diagnostics

This changes everything

Health is a dynamic state of well-being. Healthcare providers and researchers have long believed that changes in our saliva record our ongoing state-of-health story. Interestingly, saliva acts as a wide resource of genomic information useful for identifying and monitoring in real-time a disease as well as its state of progression. Saliva analysis looks at the cellular level, the biologically active compounds, making it a true representative of what is clinically relevant.

Spectrum’s technically-superior saliva collection systems have not only been engineered to lead the saliva collection industry in molecular diagnostics and clinical research applications but deliver the safest, most robust biomaterial for the earliest detection and diagnosis of disease and infection.

  • Saliva provides the earliest path to critical detection and diagnosis
  • Saliva contains the entire library of proteins, hormones, antibodies, and other molecular compounds measured in routine blood tests
  • First EUA authorized saliva collection device for COVID-19 testing & authorized device for direct-to-patient at-home sample self-collection
  • Used in supervised & unsupervised sample collection LDT workflows of symptomatic & asymptomatic users
  • Pain-free, non-invasive, & safe – ideal for those needing frequent & repeat testing
  • In-device live virus inactivation at ambient temps (COVID-19 EUA validated data)
  • Eliminates hooded containment of samples arriving at the testing lab
  • No temperature-controlled storage or transport of collected saliva samples
  • Single device for DNA & viral RNA applications
  • Safest collection approach & most robust biomaterial for detecting COVID-19
  • Delivers 99.998% highest levels of testing accuracy & sensitivity
  • Formulation identifies infections at its earliest stage from as few as 200 copies/ml (lateral flow rapid tests need 10,000-20,000 copies/ml)
  • A single preserved saliva sample provides opportunity for multiple tests
  • Over two weeks of post-collection stability with no degradation in sample efficacy
  • System maintains critical bio-sample consistency
  • Mass-testing scalability & easy device integration using validated and supported processes
  • Mitigates any risk of infection throughout the testing process
  • Pinpoint life-cycle stage of active viral infection
  • Eliminates UN3373 shipping designation with clearance from USPS, FedEx, & UPS
  • Delivers the highest levels of testing accuracy using qualified extraction chemistries
Questions, Let’s Connect!
Major League Baseball Logo

Bringing Baseball Back!

How you collect saliva makes a big
diagnostic difference

Increase workplace safety and build team confidence with simple and safe repeat testing programs supporting 100% accurate early detection and easy direct-to-user at-home options. Just ask the MLB, real-world, mass testing scenarios require an authorized, proven, and supported system that mitigates any risk of exposure. See how our saliva collection system is credited for bringing baseball back” and making Salt Lake “the league’s most important city”.

™/© 2020 MLB

Case Study
Major League Baseball Logo

Bringing Baseball Back!

How you collect saliva makes a big
diagnostic difference

Increase workplace safety and build team confidence with simple and safe repeat testing programs supporting 100% accurate early detection and easy direct-to-user at-home options. Just ask the MLB, real-world, mass testing scenarios require an authorized, proven, and supported system that mitigates any risk of exposure. See how our saliva collection system is credited for bringing baseball back” and making Salt Lake “the league’s most important city”.

™/© 2020 MLB

Case Study

Why Spectrum?

Headquartered in Salt Lake City, Utah, Spectrum Solutions is a laboratory medicine life science company using its focused industry expertise to drive noninvasive molecular diagnostic and screening IVD innovation. Our pioneering research, products, engineering, and development-to-delivery test kit commercialization capabilities are setting new standards of modernized care for patients, providers, and laboratories in the testing, managing, and treatment of disease.

We believe when you bridge the gap between science and real direct-to-patient medical solutions you deliver innovation with the practical power to impact and change outcomes. Learn more about our expertise by visiting our three fully integrated division pages: Spectrum Medical Science SM, Spectrum Compounding Pharmacy TM, and Spectrum Clinical Manufacturing SM.

#partoftheSolution

Leslie Titus Bryant Spectrum Solutions SpokesmanSpectrum Corporate Spokesman
Leslie Titus Bryant
Head of Marketing & Brand
admin@spectrumsolution.com

Tim Rush Public Relations, Springboard 5Media Contact
Tim Rush, Springboard5
801-208-1100
tim.rush@springboard5.com

Why Spectrum?

Headquartered in Salt Lake City, Utah, Spectrum Solutions is a laboratory medicine life science company using its focused industry expertise to drive noninvasive molecular diagnostic and screening IVD innovation. Our pioneering research, products, engineering, and development-to-delivery test kit commercialization capabilities are setting new standards of modernized care for patients, providers, and laboratories in the testing, managing, and treatment of disease.

We believe when you bridge the gap between science and real direct-to-patient medical solutions you deliver innovation with the practical power to impact and change outcomes. Learn more about our expertise by visiting our three fully integrated division pages: Spectrum Medical Science SM, Spectrum Compounding Pharmacy TM, and Spectrum Clinical Manufacturing SM.

#partoftheSolution

Leslie Titus Bryant Spectrum Solutions SpokesmanSpectrum Corporate Spokesman
Leslie Titus Bryant
Head of Marketing & Brand
admin@spectrumsolution.com

Tim Rush Public Relations, Springboard 5Media Contact
Tim Rush, Springboard5
801-208-1100
tim.rush@springboard5.com

Can we answer any questions?

Let's Connect

Contact Us

#SpitMatters

Can we answer any questions?

Let's Connect

Contact Us

#SpitMatters

Outside-of-the-Box Thinking, Inside-of-the-Box Clinical Innovation

Anywhere from customized testing solutions to new medical science product innovations–we’re here to help.

Outside-of-the-Box Thinking, Inside-of-the-Box Innovation

Anywhere from customized testing solutions to new medical science product innovations–we’re here to help.

2022-06-30T03:02:36+00:00
Go to Top